The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC)

被引：0
|
作者：
Stadler, W. M.
Figlin, R. A.
Ernstoff, M. S.
Curti, B.
Pendergrass, K.
Srinivas, S.
Canfield, V.
Weissman, C.
Poulin-Costello, M.
Bukowski, R. M.
机构：
[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[2] City Hope Comprehens Canc Ctr, Los Angeles, CA USA
[3] Dartmouth Med Sch, Lebanon, NH USA
[4] Providence Portland Med Ctr, Portland, OR USA
[5] Kansas City Canc Ctr, Overland Pk, KS USA
[6] Stanford Univ Hosp, Stanford, CA 94305 USA
[7] Canc Care Associates, Oklahoma City, OK USA
[8] New York Oncol Hematol, Latham, NY USA
[9] Bayer HealthCare, West Haven, CT USA
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5036
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety and Efficacy Results of the Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program in North America
    Stadler, Walter M.
    Figlin, Robert A.
    McDermott, David F.
    Dutcher, Janice P.
    Knox, Jennifer J.
    Miller, Wilson H., Jr.
    Hainsworth, John D.
    Henderson, Charles A.
    George, Jeffrey R.
    Hajdenberg, Julio
    Kindwall-Keller, Tamila L.
    Ernstoff, Marc S.
    Drabkin, Harry A.
    Curti, Brendan D.
    Chu, Luis
    Ryan, Christopher W.
    Hotte, Sebastien J.
    Xia, Chenghua
    Cupit, Lisa
    Bukowski, Ronald M.
    CANCER, 2010, 116 (05) : 1272 - 1280
  • [22] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [23] The role of immunotherapy in non-clear cell renal cell carcinoma
    Climent, Carla
    Soriano, Sandra
    Bonfill, Teresa
    Lopez, Natalia
    Rodriguez, Marta
    Sierra, Marina
    Andreu, Pablo
    Fragio, Monica
    Busquets, Mireia
    Carrasco, Alicia
    Cano, Ona
    Segui, Miguel-Angel
    Gallardo, Enrique
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Ana M. Molina
    Darren R. Feldman
    Michelle S. Ginsberg
    Glenn Kroog
    Satish K. Tickoo
    Xiaoyu Jia
    Murielle Georges
    Sujata Patil
    Michael S. Baum
    Victor E. Reuter
    Robert J. Motzer
    Investigational New Drugs, 2012, 30 : 335 - 340
  • [25] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Ginsberg, Michelle S.
    Kroog, Glenn
    Tickoo, Satish K.
    Jia, Xiaoyu
    Georges, Murielle
    Patil, Sujata
    Baum, Michael S.
    Reuter, Victor E.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 335 - 340
  • [26] Efficacy and safety of sorafenib in patients with advanced clear-cell renal cell carcinoma (RCC) with diabetes: Results from the phase III TARGET study
    Oudard, S.
    Eisen, T.
    Szczylik, C.
    Siebels, M.
    Negrier, S.
    Chevreau, C.
    Cihon, F.
    Bukowski, R. M.
    Escudier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Sorafenib therapy in the management of advanced renal cell carcinoma with brain metastases: Results from the arccs expanded access program
    Henderson, C. A.
    Bukowski, R. M.
    Stadler, W. M.
    Dutcher, J. P.
    Kindwall-Keller, T. L.
    Hotte, S. J.
    Logie, K. W.
    Baftz, B. P.
    Wilson, K.
    Figlin, R. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 245 - 245
  • [28] Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
    Costello, Brian Addis
    Thai Huu Ho
    Tan, Winston
    Leibovich, Bradley C.
    Castle, Erik P.
    Parker, Alexander S.
    Dronca, Roxana Stefania
    Qin, Rui
    Kohll, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Efficacy and safety of AMG 102 in patients with advanced renal cell carcinoma (RCC)
    Kabbinavar, F.
    Garcia, J. A.
    Stadler, W. M.
    Gil, T.
    Jonasch, E.
    Tagawa, S. T.
    Smitt, M.
    Yang, X.
    Oliner, K.
    Schoffski, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 426 - 426
  • [30] Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zhang, Tian
    George, Daniel J.
    Atkins, Michael B.
    Kelly, William J.
    Vogelzang, Nicholas J.
    Pal, Sumanta K.
    Hsu, JoAnn
    Appleman, Leonard J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345